Skip to content
Amoxicillin
Amoxil, Augmentin, Dispermox, Larotid, Moxatag, Polymox, Prevpac, Talicia, Trimox, Utimox, Voquezna, Wymox (amoxicillin) is a small molecule pharmaceutical. Amoxicillin was first approved as Amoxil on 1982-01-01. It is used to treat actinomycosis, bacterial infections, bacterial skin diseases, chlamydia infections, and duodenal ulcer amongst others in the USA.
Download report
Favorite
Searched
Top Prescription Drugs
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
digestive system diseasesD004066
respiratory tract diseasesD012140
otorhinolaryngologic diseasesD010038
urogenital diseasesD000091642
skin and connective tissue diseasesD017437
wounds and injuriesD014947
Trade Name
FDA
EMA
Combinations
Augmentin, Talicia, Voquezna dual, Voquezna triple (generic drugs available since 1982-01-01, discontinued: Prevpac)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Amoxicillin
Tradename
Company
Number
Date
Products
AMOXILGSKN-050459 DISCN1982-01-01
2 products, RLD
AMOXILGSKN-050460 DISCN1982-01-01
3 products, RLD
LAROTIDGSKN-050460 DISCN1982-01-01
1 products, RLD
MOXATAGPragma PharmaceuticalsN-050813 DISCN2008-01-23
1 products, RLD
AMOXILUSAntibioticsN-050542 DISCN1982-01-01
2 products, RLD
AMOXILUSAntibioticsN-050754 DISCN1998-07-10
2 products, RLD
AMOXILUSAntibioticsN-050760 DISCN1999-04-15
2 products, RLD
AMOXILUSAntibioticsN-050761 DISCN1999-04-15
2 products
Hide discontinued
Amoxicillin
+
Clarithromycin
+
Lansoprazole
Tradename
Company
Number
Date
Products
PREVPAC (COPACKAGED)TakedaN-050757 DISCN1997-12-02
1 products, RLD
Hide discontinued
Amoxicillin
+
Clarithromycin
+
Omeprazole
Tradename
Company
Number
Date
Products
OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLINCumberland PharmaceuticalsN-050824 DISCN2011-02-08
1 products, RLD
Hide discontinued
Amoxicillin
+
Clarithromycin
+
Vonoprazan fumarate
Tradename
Company
Number
Date
Products
VOQUEZNA TRIPLE PAKPhathom PharmaceuticalsN-215152 PEND2022-05-03
1 products, RLD
Amoxicillin
+
Clavulanate potassium
Tradename
Company
Number
Date
Products
AUGMENTIN '125'USAntibioticsN-050575 RX1984-08-06
1 products, RLD
AUGMENTIN '250'USAntibioticsN-050575 RX1984-08-06
1 products, RLD, RS
AUGMENTIN '875'USAntibioticsN-050720 RX1996-02-13
1 products, RLD
AUGMENTIN ES-600USAntibioticsN-050755 RX2001-06-22
1 products, RLD
Show 9 discontinued
Amoxicillin
+
Omeprazole magnesium
+
Rifabutin
Tradename
Company
Number
Date
Products
TALICIARedHill BiopharmaN-213004 RX2019-11-01
1 products, RLD, RS
Amoxicillin
+
Vonoprazan fumarate
Tradename
Company
Number
Date
Products
VOQUEZNA DUAL PAKPhathom PharmaceuticalsN-215153 PEND2022-05-03
1 products, RLD
Labels
FDA
EMA
Brand Name
Status
Last Update
amoxicillinANDA2023-06-17
amoxilANDA2023-01-12
augmentinNew Drug Application2023-03-21
moxatag2008-12-08
prevpacNew Drug Application2010-03-15
taliciaNew Drug Application2021-10-05
voquezna dual pak voquezna triple pakNew Drug Application2022-06-21
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
actinomycosisEFO_0007128D000196A42
bacterial infections—D001424A49
bacterial skin diseases—D017192—
chlamydia infectionsEFO_0007205D002690A74.9
duodenal ulcerEFO_0004607D004381K26
helicobacter infectionsEFO_1000961D016481—
human bites—D001734W50.3
listeriosisEFO_0007347D008088A32
lyme disease—D008193A69.2
otitis mediaEFO_0004992D010033H66.9
Show 4 more
Agency Specific
FDA
EMA
Expiration
Code
AMOXICILLIN / CLARITHROMYCIN / VONOPRAZAN FUMARATE, VOQUEZNA TRIPLE PAK, PHATHOM
2032-05-03GAIN
2027-05-03NCE
AMOXICILLIN / VONOPRAZAN FUMARATE, VOQUEZNA DUAL PAK, PHATHOM
2032-05-03GAIN
2027-05-03NCE
Patent Expiration
Patent
Expires
Flag
FDA Information
Amoxicillin / Omeprazole Magnesium / Rifabutin, Talicia, Redhill
90502632034-02-12DPU-2660
94984452034-02-12DPU-2660
96038062034-02-12DPU-2660
102386062034-02-12DP
111351722034-02-12DPU-2660
Amoxicillin / Clarithromycin / Vonoprazan Fumarate, Voquezna Triple Pak, Phathom
91864112030-08-11DP
79774882028-08-11DP
Amoxicillin, Moxatag, Pragma
82990522027-05-07U-1304
83573942026-12-08DP
87789242026-12-08DS, DPU-897
ATC Codes
A: Alimentary tract and metabolism drugs
— A02: Drugs for acid related disorders
— A02B: Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)
— A02BD: Combinations for eradication of helicobacter pylori
— A02BD01: Omeprazole, amoxicillin and metronidazole
— A02BD03: Lansoprazole, amoxicillin and metronidazole
— A02BD04: Pantoprazole, amoxicillin and clarithromycin
— A02BD05: Omeprazole, amoxicillin and clarithromycin
— A02BD06: Esomeprazole, amoxicillin and clarithromycin
— A02BD07: Lansoprazole, amoxicillin and clarithromycin
— A02BD10: Lansoprazole, amoxicillin and levofloxacin
— A02BD11: Pantoprazole, amoxicillin, clarithromycin and metronidazole
— A02BD12: Rabeprazole, amoxicillin and clarithromycin
— A02BD13: Rabeprazole, amoxicillin and metronidazole
— A02BD14: Vonoprazan, amoxicillin and clarithromycin
— A02BD15: Vonoprazan, amoxicillin and metronidazole
— A02BD16: Omeprazole, amoxicillin and rifabutin
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01C: Beta-lactam antibacterials, penicillins
— J01CA: Penicillins with extended spectrum
— J01CA04: Amoxicillin
— J01CR: Combinations of penicillins, incl. beta-lactamase inhibitors
— J01CR02: Amoxicillin and beta-lactamase inhibitor
HCPCS
Code
Description
G9313
Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis for documented reason
G9314
Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given
G9315
Documentation amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis
Clinical
Clinical Trials
525 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InfectionsD007239EFO_000054455176724113
PneumoniaD011014EFO_0003106J18241013733
Healthy volunteers/patients—11112621
GastritisD005756EFO_0000217K29.71367217
SinusitisD012852EFO_0007486J32——26513
Helicobacter infectionsD016481EFO_1000961—253312
DyspepsiaD004415EFO_0008533K3012—7111
Respiratory tract infectionsD012141J06.92—2329
Helicobacter pyloriD016480NCBITaxon_210B96.812—1519
Chronic periodontitisD055113EFO_0006343K05.3—1—539
Show 70 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223C85.9—22—15
MalnutritionD044342EFO_0008572E40-E46——1—34
TuberculosisD014376EFO_0000774A15-A19111——3
Diabetic footD017719EFO_1001459——2—13
NeutropeniaD009503D70——2—13
NeoplasmsD009369C80——2—13
SepsisD018805A41.9——1—23
PharyngitisD010612R07.0——2—13
Bacterial pneumoniaD018410EFO_1001272J15.9—11——2
Intraabdominal infectionsD059413——2——2
Show 34 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pulmonary tuberculosisD014397EFO_1000049A15—5———5
ObesityD009765EFO_0001073E66.911——23
Insulin resistanceD007333EFO_0002614—1——12
Ulcerative colitisD003093EFO_0000729K51—1——12
TonsillectomyD01406811——12
AsthmaD001249EFO_0000270J45—1———1
Liver diseasesD008107EFO_0001421K70-K77—1———1
Fatty liverD005234—1———1
Chlamydia infectionsD002690EFO_0007205A74.9—1———1
Gram-negative bacterial infectionsD016905—1———1
Show 8 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Gastrointestinal diseasesD0057671———12
Jaw fracturesD0075721————1
Morbid obesityD009767EFO_00010741————1
Dental implantsD0159211————1
InflammationD0072491————1
Drug interactionsD0043471————1
Short bowel syndromeD0127781————1
Congenital syphilisD013590EFO_0007219A501————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MalariaD008288EFO_0001068B54————22
Hiv infectionsD015658EFO_0000764B20————22
Protein-energy malnutritionD011502EFO_0009563E41————22
KwashiorkorD007732EFO_1001009E40————22
Thyroid noduleD016606EFO_1001436————22
Periapical periodontitisD010485EFO_1001391K04.5————22
Salmonella infectionsD012480EFO_1001418A02.9————11
Bisphosphonate-associated osteonecrosis of the jawD059266————11
Peritonsillar abscessD000039EFO_0007429J36————11
Chemical and drug induced liver injuryD056486————11
Show 31 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameAMOXICILLIN
INNamoxicillin
Description
Amoxicillin is a penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-(4-hydroxyphenyl)acetamido group. It has a role as an antibacterial drug. It is a penicillin and a penicillin allergen. It is a conjugate acid of an amoxicillin(1-).
Classification
Small molecule
Drug classpenicillins
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O
Identifiers
PDB—
CAS-ID26787-78-0
RxCUI1297882
ChEMBL IDCHEMBL1082
ChEBI ID2676
PubChem CID33613
DrugBankDB01060
UNII ID9EM05410Q9 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 58,471 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
1,084 adverse events reported
View more details